Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia.

Trial Profile

Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 29 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top